Statin utilization in nursing home patients after cardiac hospitalization

Journal of General Internal Medicine

Volumn 25, Issue 12, 2010, Pages 1293-1299

  Parikh, Seema ^a,b,c,d   Shrank, William H ^a   Mogun, Helen ^a   Choudhry, Niteesh K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Hebrew Senior Life   (United States)

^d Caulfield General Medical Center   (Australia)

Author keywords

drugs; geriatrics; pharmacoepidemiology; prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TICLOPIDINE; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG UTILIZATION; FEMALE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICARE; MIDDLE AGED; NEW JERSEY; NURSING HOMES; PATIENT DISCHARGE; UNITED STATES;

EID: 78649924144     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1473-z     Document Type: Article

References (28)

1. P Kemper CM Murtaugh 1991 Lifetime use of nursing home care N Engl J Med 324 595 600 1:STN:280:DyaK3M7isFChuw%3D%3D 10.1056/NEJM199102283240905 1992320
2. WS Aronow 2000 Clinical causes of death of 2372 older persons in a nursing home during 15-year follow-up J Am Med Dir Assoc 1 95 6 1:STN:280:DC%2BD3s3ptF2luw%3D%3D 12818019
3. WS Aronow C Ahn H Gutstein 2002 Prevalence and incidence of cardiovascular disease in 1,160 older men and 2,464 older women in a long-term health care facility J Gerontol A Biol Sci Med Sci 57 M45 6 11773211
4. A Segev BH Strauss M Tan, et al. 2006 Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries) Am J Cardiol 98 470 3 10.1016/j.amjcard.2006.03.023 16893699 (Pubitemid 44162872)
5. KL Grady 1993 Quality of life in patients with chronic heart failure Crit Care Nurs Clin North Am 5 661 70 1:STN:280:DyaK2c7ivVejsA%3D%3D 8297555
6. R Mayou R Blackwood B Bryant J Garnham 1991 Cardiac failure: symptoms and functional status J Psychosom Res 35 399 407 1:STN:280:DyaK38%2FhsV2jug%3D%3D 10.1016/0022-3999(91)90035-M 1920171
7. HS Javitz MM Ward JB Watson M Jaana 2004 Cost of illness of chronic angina Am J Manag Care 10 S358 69 15603245
8. M Lye R Valacio JP Reckless, et al. 1998 Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin Coron Artery Dis 9 583 90 1:STN:280: DyaK1M%2FnvVGisQ%3D%3D 10.1097/00019501-199809090-00005 9861520
9. S Ward M Lloyd Jones A Pandor, et al. 2007 A systematic review and economic evaluation of statins for the prevention of coronary events Health Technol Assess 11 1 160 iii-iv
10. S DeWilde IM Carey SA Bremner N Richards SR Hilton DG Cook 2003 Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart 89 417 21 1:STN:280:DC%2BD3s7isFKnsQ%3D%3D 10.1136/heart.89.4.417 12639870
11. SC Smith Jr J Allen SN Blair, et al. 2006 AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2363 72 10.1161/CIRCULATIONAHA.106.174516 16702489 (Pubitemid 43947981)
12. CB Eaton KL Lapane JB Murphy AL Hume 2002 Effect of statin (HMG-Co-A-reductase inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes J Am Geriatr Soc 50 1389 95 10.1046/j.1532-5415.2002.50360.x 12164995
13. U.S. Dept. of Health and Human Services, National Center for Health Statistics. National Nursing Home Survey, 1999.
14. MA Williams JL Fleg PA Ades, et al. 2002 Secondary prevention of coronary heart disease in the elderly (with emphasis on patients≥75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention Circulation 105 1735 43 10.1161/01.CIR.0000013074.73995.6C 11940556 (Pubitemid 34298621)
15. A Kulik R Levin M Ruel TG Mesana DH Solomon NK Choudhry 2007 Patterns and predictors of statin use after coronary artery bypass graft surgery J Thorac Cardiovasc Surg 134 932 8 10.1016/j.jtcvs.2007.05.039 17903510 (Pubitemid 47445596)
16. NK Choudhry R Levin WC Winkelmayer 2007 Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice Heart 93 945 51 1:CAS:528:DC%2BD2sXpsFartLw%3D 10.1136/hrt.2006.110197 17344334 (Pubitemid 47122045)
17. SJ Shah DD Waters P Barter, et al. 2008 Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery J Am Coll Cardiol 51 1938 43 1:CAS:528:DC%2BD1cXlvFOqsb4%3D 10.1016/j.jacc.2007.12.054 18482661 (Pubitemid 351636440)
18. S Setoguchi RJ Glynn J Avorn R Levin WC Winkelmayer 2007 Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons≥65 years of age Am J Cardiol 100 1061 7 10.1016/j.amjcard.2007.04.052 17884362 (Pubitemid 47404456)
19. X Ye CR Gross J Schommer R Cline J Xuan WL St Peter 2007 Initiation of statins after hospitalization for coronary heart disease J Manag Care Pharm 13 385 96 17605510
20. J Joseph M Koka WS Aronow 2008 Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home J Am Med Dir Assoc 9 124 7 10.1016/j.jamda.2007.10.010 18261706
21. S Ghosh V Ziesmer WS Aronow 2002 Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home J Gerontol A Biol Sci Med Sci 57 M398 400 12023270
22. V Adhiyaman D Kamalakannan A Oke IU Shah AD White 2000 Underutilization of antithrombotic therapy in atrial fibrillation J R Soc Med 93 138 40 1:STN:280:DC%2BD3c3gsFCrtQ%3D%3D 10741314
23. G Mendelson WS Aronow 1998 Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke J Am Geriatr Soc 46 1423 4 1:STN:280:DyaK1M%2FisFKgug%3D%3D 9809766
24. G Mendelson WS Aronow 1998 Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice J Am Geriatr Soc 46 751 2 1:CAS:528:DyaK1cXktVSktLw%3D 9625192
25. CR Levy TA Radcliff ET Williams E Hutt 2009 Acute myocardial infarction in nursing home residents: adherence to treatment guidelines reduces mortality, but why is adherence so low? J Am Med Dir Assoc 10 56 61 10.1016/j.jamda.2008. 08.009 19111854
26. J Shepherd GJ Blauw MB Murphy, et al. 2002 Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 1623 30 1:CAS:528:DC%2BD38XovFegt7o%3D 10.1016/S0140-6736(02)11600-X 12457784 (Pubitemid 35379733)
27. JV Agostini ME Tinetti L Han G McAvay JM Foody J Concato 2007 Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults J Am Geriatr Soc 55 420 5 10.1111/j.1532-5415.2007.01071.x 17341246 (Pubitemid 46328106)
28. Aronow WS. Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol>125 mg/dl. Am J Cardiol 1998; 82: 668-9, A6, A8.